Xencor, Inc. (XNCR) Stock Forecast
Data as of May 2, 2026Healthcare · Current price $12.88 (+7.88%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Oct 29, 2025 | Etzer Darout | Barclays | $23.00 | +78.6% |
| Oct 27, 2025 | Gregory Renza | RBC Capital | $18.00 | +39.8% |
| Aug 7, 2025 | David Nierengarten | Wedbush | $26.00 | +101.9% |
| Dec 2, 2024 | Edward Tenthoff | Piper Sandler | $30.00 | +133.0% |
| Jun 14, 2024 | Etzer Darout | BMO Capital | $32.00 | +148.5% |
| Jun 14, 2024 | Gregory Renza | RBC Capital | $31.00 | +140.8% |
| Apr 16, 2024 | Kaveri Pohlman | BTIG | $38.00 | +195.1% |
| Oct 4, 2021 | Charles Zhu | Guggenheim | $54.00 | +319.4% |
| May 5, 2021 | Dane Leone | Raymond James | $58.00 | +350.5% |
Top Analysts Covering XNCR
XNCR vs Sector & Market
| Metric | XNCR | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.17 | 2.24 | 2.41 |
| Analyst Count | 6 | 8 | 18 |
| Target Upside | +151.1% | +1150.1% | +14.9% |
| P/E Ratio | -9.81 | 6.88 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $27M | $117M | $204M | 10 |
| 2027-03-31 | $5M | $27M | $57M | 4 |
| 2027-06-30 | $5M | $28M | $58M | 4 |
| 2027-09-30 | $5M | $28M | $59M | 5 |
| 2027-12-31 | $6M | $30M | $64M | 4 |
| 2028-03-31 | $10M | $51M | $108M | 3 |
| 2028-06-30 | $10M | $51M | $108M | 3 |
| 2028-09-30 | $10M | $51M | $108M | 5 |
| 2028-12-31 | $10M | $51M | $108M | 3 |
| 2029-12-31 | $54M | $266M | $548M | 4 |
| 2030-12-31 | $105M | $520M | $1.07B | 4 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $-4.61 | $-2.90 | $0.05 | 11 |
| 2027-03-31 | $-1.96 | $-0.80 | $0.05 | 3 |
| 2027-06-30 | $-2.02 | $-0.83 | $0.05 | 5 |
| 2027-09-30 | $-1.97 | $-0.81 | $0.05 | 3 |
| 2027-12-31 | $-1.85 | $-0.76 | $0.04 | 6 |
| 2028-03-31 | $-1.65 | $-0.67 | $0.04 | 4 |
| 2028-06-30 | $-1.68 | $-0.69 | $0.04 | 6 |
| 2028-09-30 | $-1.65 | $-0.68 | $0.04 | 4 |
| 2028-12-31 | $-1.66 | $-0.68 | $0.04 | 7 |
| 2029-12-31 | $-3.68 | $-1.55 | $0.06 | 3 |
| 2030-12-31 | $-0.06 | $-0.03 | $0.00 | 3 |
Frequently Asked Questions
What is the analyst consensus for XNCR?
The consensus among 6 analysts covering Xencor, Inc. (XNCR) is Buy with an average price target of $28.75.
What is the highest price target for XNCR?
The highest price target for XNCR is $58.00, set by Dane Leone at Raymond James on 2021-05-05.
What is the lowest price target for XNCR?
The lowest price target for XNCR is $18.00, set by Gregory Renza at RBC Capital on 2025-10-27.
How many analysts cover XNCR?
6 analysts have issued ratings for Xencor, Inc. in the past 12 months.
Is XNCR a buy or sell right now?
Based on 6 analyst ratings, XNCR has a consensus rating of Buy (2.17/5) with a +151.1% upside to the consensus target of $28.75.
What are the earnings estimates for XNCR?
Analysts estimate XNCR will report EPS of $-2.90 for the period ending 2026-12-31, with revenue estimated at $117M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.